BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 28601065)

  • 1. Mazes of Nrf2 Regulation.
    Zenkov NK; Kozhin PM; Chechushkov AV; Martinovich GG; Kandalintseva NV; Menshchikova EB
    Biochemistry (Mosc); 2017 May; 82(5):556-564. PubMed ID: 28601065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Keap1-Nrf2 system as an in vivo sensor for electrophiles.
    Uruno A; Motohashi H
    Nitric Oxide; 2011 Aug; 25(2):153-60. PubMed ID: 21385624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular cross-talk between the NRF2/KEAP1 signaling pathway, autophagy, and apoptosis.
    Stępkowski TM; Kruszewski MK
    Free Radic Biol Med; 2011 May; 50(9):1186-95. PubMed ID: 21295136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution.
    Taguchi K; Motohashi H; Yamamoto M
    Genes Cells; 2011 Feb; 16(2):123-40. PubMed ID: 21251164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetyl-l-carnitine prevents homocysteine-induced suppression of Nrf2/Keap1 mediated antioxidation in human lens epithelial cells.
    Yang SP; Yang XZ; Cao GP
    Mol Med Rep; 2015 Jul; 12(1):1145-50. PubMed ID: 25776802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Dual Roles of NRF2 in Cancer.
    Menegon S; Columbano A; Giordano S
    Trends Mol Med; 2016 Jul; 22(7):578-593. PubMed ID: 27263465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Molecular Mechanisms Regulating the KEAP1-NRF2 Pathway.
    Baird L; Yamamoto M
    Mol Cell Biol; 2020 Jun; 40(13):. PubMed ID: 32284348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Keap1-Nrf2 system and diabetes mellitus.
    Uruno A; Yagishita Y; Yamamoto M
    Arch Biochem Biophys; 2015 Jan; 566():76-84. PubMed ID: 25528168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prothyomosin alpha interaction with KEAP1 doesn't lead to prothymosin alpha ubiquination and degradation].
    Mel'nikov SV; Evstaf'eva AG; Vartapetian AB
    Mol Biol (Mosk); 2007; 41(5):868-75. PubMed ID: 18240569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of Nrf2 in oxidative stress-induced endothelial injuries.
    Chen B; Lu Y; Chen Y; Cheng J
    J Endocrinol; 2015 Jun; 225(3):R83-99. PubMed ID: 25918130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continued 26S proteasome dysfunction in mouse brain cortical neurons impairs autophagy and the Keap1-Nrf2 oxidative defence pathway.
    Ugun-Klusek A; Tatham MH; Elkharaz J; Constantin-Teodosiu D; Lawler K; Mohamed H; Paine SM; Anderson G; John Mayer R; Lowe J; Ellen Billett E; Bedford L
    Cell Death Dis; 2017 Jan; 8(1):e2531. PubMed ID: 28055010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulation of the Keap1-Nrf2 pathway in cancer.
    Leinonen HM; Kansanen E; Pölönen P; Heinäniemi M; Levonen AL
    Biochem Soc Trans; 2015 Aug; 43(4):645-9. PubMed ID: 26551706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canonical and non-canonical mechanisms of Nrf2 activation.
    Silva-Islas CA; Maldonado PD
    Pharmacol Res; 2018 Aug; 134():92-99. PubMed ID: 29913224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer Cell Growth Is Differentially Affected by Constitutive Activation of NRF2 by KEAP1 Deletion and Pharmacological Activation of NRF2 by the Synthetic Triterpenoid, RTA 405.
    Probst BL; McCauley L; Trevino I; Wigley WC; Ferguson DA
    PLoS One; 2015; 10(8):e0135257. PubMed ID: 26301506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nrf2-Keap1 signaling in oxidative and reductive stress.
    Bellezza I; Giambanco I; Minelli A; Donato R
    Biochim Biophys Acta Mol Cell Res; 2018 May; 1865(5):721-733. PubMed ID: 29499228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Keap1 controls postinduction repression of the Nrf2-mediated antioxidant response by escorting nuclear export of Nrf2.
    Sun Z; Zhang S; Chan JY; Zhang DD
    Mol Cell Biol; 2007 Sep; 27(18):6334-49. PubMed ID: 17636022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers.
    Yamadori T; Ishii Y; Homma S; Morishima Y; Kurishima K; Itoh K; Yamamoto M; Minami Y; Noguchi M; Hizawa N
    Oncogene; 2012 Nov; 31(45):4768-77. PubMed ID: 22249257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic modifications but not genetic polymorphisms regulate KEAP1 expression in colorectal cancer.
    Gao L; Yuan F; Che G; Xiao X; Nie X; Wang Y; Jia J; Kong AN; Zhang L
    J Cell Biochem; 2019 Aug; 120(8):12311-12320. PubMed ID: 30825237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and epigenetic regulation of the NRF2-KEAP1 pathway in human lung cancer.
    Camiña N; Penning TM
    Br J Cancer; 2022 May; 126(9):1244-1252. PubMed ID: 34845361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CR6-interacting factor 1 (CRIF1) regulates NF-E2-related factor 2 (NRF2) protein stability by proteasome-mediated degradation.
    Kang HJ; Hong YB; Kim HJ; Bae I
    J Biol Chem; 2010 Jul; 285(28):21258-68. PubMed ID: 20427290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.